Literature DB >> 2238715

Orthopaedic manifestations of sickle-cell disease.

M H Huo1, G E Friedlaender, J S Marsh.   

Abstract

Sickle-cell disease is a well-recognized clinical entity. The pathophysiology of this hemoglobinopathy has been described in detail by numerous investigators since the first case report appeared in 1910. Orthopaedic manifestations of sickle-cell disease account for much of the morbidity associated with this disorder, including pain, osteonecrosis, arthritis, and sepsis. Effective management of these bone and joint sequelae reflect accurate diagnosis, understanding of this disorder's pathophysiology, and knowledge of available medical and surgical treatment alternatives. In this review, the authors summarize the major orthopaedic manifestations of sickle-cell disease with special emphasis placed upon osteonecrosis and osteomyelitis, since these conditions are the most disabling and serious complications in patients with sickle-cell disease.

Entities:  

Mesh:

Year:  1990        PMID: 2238715      PMCID: PMC2589295     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  50 in total

1.  The bone changes in sickle cell anaemia and its genetic variants.

Authors:  J S GOLDING; J E MACIVER; L N WENT
Journal:  J Bone Joint Surg Br       Date:  1959-11

2.  Salmonella osteomyelitis in patients with sickle-cell anemia.

Authors:  E W HOOK; C G CAMPBELL; H S WEENS; G R COOPER
Journal:  N Engl J Med       Date:  1957-08-29       Impact factor: 91.245

3.  Osteomyelitis in the patient with sickle-cell disease.

Authors:  C A Engh; J L Hughes; R C Abrams; J W Bowerman
Journal:  J Bone Joint Surg Am       Date:  1971-01       Impact factor: 5.284

4.  Acute long bone diaphyseal infarcts in sickle cell disease.

Authors:  S P Bohrer
Journal:  Br J Radiol       Date:  1970-10       Impact factor: 3.039

5.  Bone and joint infection in patients with sickle cell disease.

Authors:  A Mallouh; Y Talab
Journal:  J Pediatr Orthop       Date:  1985 Mar-Apr       Impact factor: 2.324

Review 6.  Sickle cell anemia and related hemoglobinopathies.

Authors:  E P Vichinsky; B H Lubin
Journal:  Pediatr Clin North Am       Date:  1980-05       Impact factor: 3.278

7.  Evaluation of magnetic resonance imaging in the diagnosis of osteonecrosis of the femoral head. Accuracy compared with radiographs, core biopsy, and intraosseous pressure measurements.

Authors:  H J Robinson; P D Hartleben; G Lund; J Schreiman
Journal:  J Bone Joint Surg Am       Date:  1989-06       Impact factor: 5.284

8.  Scintigraphic differentiation of bone infarction from osteomyelitis in children with sickle cell disease.

Authors:  S Rao; N Solomon; S Miller; E Dunn
Journal:  J Pediatr       Date:  1985-11       Impact factor: 4.406

9.  Sickle cell disease associated with uric acid deposition disease.

Authors:  B M Rothschild; C W Sienknecht; S B Kaplan; J S Spindler
Journal:  Ann Rheum Dis       Date:  1980-08       Impact factor: 19.103

10.  Observations on the sequential use of 99mTc-phosphate complex and 67Ga imaging in osteomyelitis, cellulitis, and septic arthritis.

Authors:  R Losbona; L Rosenthall
Journal:  Radiology       Date:  1977-04       Impact factor: 11.105

View more
  5 in total

Review 1.  Rheumatological manifestations of haematological diseases.

Authors:  S Menon; D A Isenberg
Journal:  Ann Rheum Dis       Date:  1995-10       Impact factor: 19.103

2.  Osteoarticular involvement in sickle cell disease.

Authors:  Geraldo Bezerra da Silva Junior; Elizabeth De Francesco Daher; Francisco Airton Castro da Rocha
Journal:  Rev Bras Hematol Hemoter       Date:  2012

3.  Pilot randomized controlled trial to evaluate the effect of aquatic and land physical therapy on musculoskeletal dysfunction of sickle cell disease patients.

Authors:  Camila Tatiana Zanoni; Fábio Galvão; Alberto Cliquet Junior; Sara Teresinha Olalla Saad
Journal:  Rev Bras Hematol Hemoter       Date:  2014-11-21

Review 4.  Review of Sickle Cell Disease and Spinal Pathology.

Authors:  Hayeem L Rudy; David Yang; Andrew D Nam; Woojin Cho
Journal:  Global Spine J       Date:  2018-09-17

5.  Percutaneous implantation of autologous bone marrow osteoprogenitor cells as treatment of bone avascular necrosis related to sickle cell disease.

Authors:  Philippe Hernigou; Gilsasio Daltro; Paolo Filippini; Martin Mukisi Mukasa; Olivier Manicom
Journal:  Open Orthop J       Date:  2008-04-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.